Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$763
|
$720B |
13.4x |
32.9x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$168
|
$437B |
4.8x |
13.1x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$191
|
$402B |
6.9x |
15.1x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$83
|
$233B |
3.6x |
8.3x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$304
|
$212B |
6.1x |
11.4x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$24
|
$182B |
2.9x |
7.4x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$114
|
$159B |
5.5x |
12.3x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$47
|
$135B |
2.9x |
10.6x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$468
|
$116B |
10.0x |
33.4x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$151
|
$72.3B |
7.7x |
17.8x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$24.3B |
1.7x |
5.6x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$128
|
$22.8B |
2.4x |
7.2x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$37
|
$21.5B |
7.4x |
8.0x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$134
|
$12.8B |
5.0x |
21.5x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$11.0B |
1.8x |
5.7x |
Verona Pharma
|
United States of America |
Biopharmaceuticals
|
$105
|
$8.8B |
33.2x |
-217.5x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$59
|
$8.0B |
7.0x |
11.0x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$5.1B |
1.7x |
7.8x |
ADMA Biologics
|
United States of America |
Biopharmaceuticals
|
$18
|
$4.4B |
9.3x |
21.2x |
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$4.2B |
7.6x |
21.9x |
Endo
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$24
|
$3.9B |
N/A |
N/A |
Ascentage Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$40
|
$3.7B |
37.2x |
-46.8x |
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$27
|
$3.5B |
2.4x |
8.9x |
Metsera
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$37
|
$3.4B |
N/A |
N/A |
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$37
|
$3.2B |
1150.9x |
-11.4x |
Procaps Group
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$1
|
$2.8B |
N/A |
N/A |
Kiniksa Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$30
|
$2.0B |
3.6x |
59.8x |
Belite Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$63
|
$1.9B |
N/A |
N/A |
ANI Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$64
|
$1.9B |
2.6x |
10.3x |
NewAmsterdam Pharma Co
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$23
|
$1.7B |
57.9x |
N/A |
Arcutis Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$15
|
$1.7B |
6.4x |
-22.0x |
Collegium Pharmaceutical
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$31
|
$1.6B |
2.4x |
3.9x |
Cogent Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$12
|
$1.5B |
N/A |
-6.9x |
Travere Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$16
|
$1.5B |
4.5x |
-10.8x |
Supernus Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$33
|
$1.4B |
2.2x |
8.4x |
Amphastar Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$22
|
$1.4B |
2.0x |
5.4x |
Harrow
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$35
|
$1.4B |
5.7x |
24.0x |
Disc Medicine
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$60
|
$1.4B |
N/A |
-8.5x |
Celcuity
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$39
|
$1.4B |
N/A |
-10.3x |
Tarsus Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$40
|
$1.4B |
4.4x |
-15.8x |
Innoviva
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$18
|
$1.2B |
3.2x |
N/A |
OPKO Health
|
United States of America |
Biopharmaceuticals,
Medical Imaging & Diagnostics
|
$1
|
$1.1B |
1.7x |
-9.8x |
WAVE Life Sciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$1.1B |
13.8x |
-7.0x |
Xeris Biopharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$5
|
$1.0B |
4.2x |
50.0x |
Sana Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$4
|
$990M |
N/A |
-4.6x |
Pharvaris
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$20
|
$979M |
N/A |
-5.5x |
Aurinia Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$9
|
$973M |
3.9x |
N/A |
Dynavax
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$11
|
$967M |
3.1x |
30.2x |
Avadel Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$966M |
4.4x |
55.5x |
Ardelyx
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$4
|
$950M |
2.7x |
-41.2x |
Enliven Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$20
|
$894M |
216403.5x |
-7.3x |
Emergent BioSolutions
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$6
|
$869M |
0.9x |
4.9x |
Akebia Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$4
|
$861M |
4.7x |
N/A |
Spyre Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$17
|
$857M |
14827.9x |
-4.0x |
Anavex Life Sciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$11
|
$854M |
N/A |
N/A |
Praxis Precision Medicines
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$56
|
$811M |
198.0x |
-3.4x |
UroGen Pharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$19
|
$802M |
7.3x |
-7.1x |
Zymeworks
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$14
|
$764M |
7.9x |
-6.6x |
89bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$9
|
$744M |
N/A |
-2.1x |
ORIC Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$11
|
$740M |
N/A |
-5.4x |
LENZ Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$32
|
$699M |
141.5x |
-9.9x |
Oculis Holding
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$18
|
$693M |
782.1x |
-7.4x |
Ironwood Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1
|
$635M |
2.1x |
6.3x |
Phathom Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$9
|
$593M |
5.1x |
-2.9x |
Elite Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1
|
$583M |
N/A |
N/A |
ArriVent BioPharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$20
|
$568M |
N/A |
-6.0x |
Mineralys Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$14
|
$562M |
N/A |
-2.9x |
Sionna Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$18
|
$553M |
N/A |
-6.1x |
Arbutus Biopharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$3
|
$521M |
89.0x |
N/A |
Tango Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$6
|
$520M |
15.1x |
N/A |
Mind Medicine
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$9
|
$499M |
N/A |
-4.4x |
Esperion Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1
|
$474M |
1.4x |
16.9x |
Dianthus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$21
|
$428M |
89.1x |
N/A |
Maze Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Digital Therapeutics
|
$16
|
$426M |
5.9x |
-6.9x |
Nuvation Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$2
|
$387M |
34.3x |
N/A |
Syndax
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$10
|
$375M |
4.6x |
-1.1x |
Nika Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$0
|
$367M |
N/A |
N/A |
Zenas BioPharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$16
|
$360M |
37.4x |
-2.1x |
CytoDyn
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$0
|
$357M |
N/A |
N/A |
SIGA Technologies
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$339M |
2.6x |
5.5x |
Tourmaline Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$23
|
$336M |
87.1x |
N/A |
Stoke Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$13
|
$327M |
2.7x |
-8.2x |
Upstream Bio
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$14
|
$322M |
166.1x |
-2.7x |
Savara
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$3
|
$315M |
N/A |
N/A |
Aura Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$7
|
$311M |
N/A |
N/A |
Lexicon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$1
|
$296M |
13.2x |
-1.9x |
Rapport Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$15
|
$286M |
N/A |
-2.5x |
Tyra Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$11
|
$283M |
N/A |
-2.4x |
MBX Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$15
|
$259M |
N/A |
-2.8x |
Alpha Teknova
|
United States of America |
Contract Research & Manufacturing,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$5
|
$259M |
6.6x |
-20.5x |
Septerna
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Small Molecules
|
$13
|
$256M |
3.2x |
-3.6x |
Day One Biopharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$7
|
$238M |
1.7x |
-1.3x |
Regenxbio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$237M |
1.1x |
-4.2x |
Alumis
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$4
|
$231M |
15.3x |
-0.8x |
Xencor
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$9
|
$224M |
2.0x |
-1.2x |
OmniAb
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$2
|
$218M |
8.9x |
-4.9x |
Mereo BioPharma Group
|
United States of America |
Biopharmaceuticals
|
$2
|
$212M |
9.9x |
-8.0x |
Armata Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$2
|
$211M |
39.3x |
-4.6x |
Cullinan Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$191M |
50.8x |
-0.9x |
Erasca
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$2
|
$185M |
N/A |
-1.1x |